[高心室节律失常时的口服抗凝剂]
Philipp Bengel1, Samuel Sossalla2,3, Borislav Dinov2
1Medizinischen Klinik I, Abteilung für Kardiologie, Universitätsklinikum Gießen, Klinikstr. 33, 35392, Gießen, Deutschland. philipp.bengel@innere.med.uni-giessen.de.
Innere Medizin (Heidelberg, Germany)
|July 15, 2024
概括
口服抗凝剂 (OAC) 对于预防心房患者中风至关重要. 目前的指导方针使用CHA2DS2-VASc评分,但切除后和亚临床心律失常后OAC的最佳使用仍然不清楚,需要仔细评估风险和益处.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心房动是最常见的心律失常,增加了发病率和死亡率.
- 口服抗凝剂 (OAC) 对于这些患者的中风预防至关重要.
- 直接口服抗凝剂 (DOAC) 现在是标准的,由于有效性和安全性,取代了维生素K对抗剂.
研究的目的:
- 审查当前的做法,并解决未解决的问题在心房的OAC.
- 讨论肺静脉切除后OAC的作用.
- 为了探索OAC启动亚临床心房动和高频发作.
主要方法:
- 审查当前文学和临床指导方针在心房的OAC.
- 使用CHA2DS2-VASc得分对中风风险分层的分析.
- 讨论有关OAC管理的证据,包括切除后的OAC管理和设备检测的心律失常.
主要成果:
- 在心房动中,DOACs对于预防中风是有效的,并且通常是安全的.
- 切除后的最佳OAC持续时间和对亚临床/设备检测AF的OAC启动标准尚未确定.
- 在OAC决策中,平衡中风预防益处与出血风险至关重要.
结论:
- 虽然OAC是心房动的标准,但特定的临床情景需要进一步澄清.
- 需要进一步的研究来指导OAC在成功切除后的使用以及亚临床心律失常.
- 需要个性化治疗决策,权衡中风风险与出血并发症.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
822
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
822
Disturbances in Heart Rhythm
932
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
932
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
964
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
964


